Current trending indicates a reportable potential for the
K163N polymorphism on the
Hemagglutinin of
PF11. This change may enhance Vaccine Escape from the currently selected vaccine target candidate, CA/07 X181.
- 33% probability of HA 163N (AAc) in PF11 within 90 days.
- 25% probability of HA 163N (AAt) in PF11 within 120 days.
These probabilities will be updated as additional data is made public. A rising potential also exists for additional
HA 163E instances to be reported sporadically in the next 6 months. Transparency at this stage of the pandemic is essential. Release of sequences and clinical data of a finer detail and higher quantity will allow information-based decisions.
Please visit GeneWurx.com for insight into the latest published studies.
